Literature DB >> 18953580

Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.

Li-Juan Fu1, Jin-Xia Li, Xiao-Gai Yang, Kui Wang.   

Abstract

The aim of this study was to investigate whether Gd is able to exert the proliferation-promoting effect and to explore its possible underlying mechanism. We showed that Gd promoted cell cycle progression with increased S-phase entry in a concentration- and time-dependent manner in NIH 3T3 cells. The effect was further evidenced by the expressions of key proteins in driving cells through the G(1)/S transition point of the cell cycle. In the presence of Gd, the protein levels of cyclins D, E, and A were dramatically increased and demonstrated a characteristically temporal pattern of sequential mitotic events. Additionally, the levels of phosphorylated retinoblastoma protein were also significantly increased at certain time periods. To further elucidate the underlying mechanism, extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling pathways were assessed. Both pathways were activated by Gd. Moreover, the levels of cyclin D and cyclin A were evaluated after the addition of the pharmacological inhibitors at early and late G(1) phases, correspondingly, to reveal the contribution of the two pathways in the Gd-promoted G(1)/S transition. It showed that both pathways were needed for Gd-promoted cell cycle progression. The results presented here provide novel evidence to advance knowledge leading to further understanding of the mechanisms of both cell growth and death caused by Gd and may be helpful for more rational application of Gd-based compounds in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18953580     DOI: 10.1007/s00775-008-0442-z

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  54 in total

1.  Gadolinium decreases stretch-induced vulnerability to atrial fibrillation.

Authors:  F Bode; A Katchman; R L Woosley; M R Franz
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

Review 2.  ERK implication in cell cycle regulation.

Authors:  Jean-Claude Chambard; Renaud Lefloch; Jacques Pouysségur; Philippe Lenormand
Journal:  Biochim Biophys Acta       Date:  2006-11-17

3.  La(3+)-induced extracellular signal-regulated kinase (ERK) signaling via a metal-sensing mechanism linking proliferation and apoptosis in NIH 3T3 cells.

Authors:  Siwang Yu; Jian Hu; Xiaoda Yang; Kui Wang; Zhong Ming Qian
Journal:  Biochemistry       Date:  2006-09-19       Impact factor: 3.162

4.  La3+-promoted proliferation is interconnected with apoptosis in NIH 3T3 cells.

Authors:  Siwang Yu; Lan Yuan; Xiaoda Yang; Kui Wang; Ya Ke; Zhong Ming Qian
Journal:  J Cell Biochem       Date:  2005-02-15       Impact factor: 4.429

5.  Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats--analysis of mechanisms of lethality in endotoxemia.

Authors:  Y Iimuro; M Yamamoto; H Kohno; J Itakura; H Fujii; Y Matsumoto
Journal:  J Leukoc Biol       Date:  1994-06       Impact factor: 4.962

Review 6.  GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.

Authors:  Fumi Takahashi-Yanaga; Toshiyuki Sasaguri
Journal:  Cell Signal       Date:  2007-10-23       Impact factor: 4.315

7.  Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.

Authors:  Seyed Isaac Hashemy; Johanna S Ungerstedt; Farnaz Zahedi Avval; Arne Holmgren
Journal:  J Biol Chem       Date:  2006-02-14       Impact factor: 5.157

Review 8.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

9.  Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis.

Authors:  M Edward; J A Quinn; S Mukherjee; M-B V Jensen; A G Jardine; P B Mark; A D Burden
Journal:  J Pathol       Date:  2008-04       Impact factor: 7.996

Review 10.  Can the risk of gadolinium be extrapolated to lanthanum?

Authors:  Marc E De Broe
Journal:  Semin Dial       Date:  2008-02-01       Impact factor: 3.455

View more
  5 in total

1.  Magnetic resonance functional nano-hydroxyapatite incorporated poly(caprolactone) composite scaffolds for in situ monitoring of bone tissue regeneration by MRI.

Authors:  Nitya Ganesh; Anusha Ashokan; Ramiah Rajeshkannan; Krishnaprasad Chennazhi; Manzoor Koyakutty; Shantikumar V Nair
Journal:  Tissue Eng Part A       Date:  2014-08-20       Impact factor: 3.845

2.  Integrin-mediated signaling contributes to gadolinium-containing-particle-promoted cell survival and G₁ to S phase cell cycle transition by enhancing focal adhesion formation.

Authors:  Jin-Xia Li; Li-Juan Fu; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2011-11-16       Impact factor: 3.358

3.  Gadolinium-containing bioparticles as an active entity to promote cell cycle progression in mouse embryo fibroblast NIH3T3 cells.

Authors:  Jin-Xia Li; Jing-Cheng Liu; Kui Wang; Xiao-Gai Yang
Journal:  J Biol Inorg Chem       Date:  2010-01-14       Impact factor: 3.358

Review 4.  Benefits and Detriments of Gadolinium from Medical Advances to Health and Ecological Risks.

Authors:  Colin Unruh; Nicolas Van Bavel; Max Anikovskiy; Elmar J Prenner
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

5.  Gadolinium-doped bioglass scaffolds promote osteogenic differentiation of hBMSC via the Akt/GSK3β pathway and facilitate bone repair in vivo.

Authors:  Dao-Yu Zhu; Bin Lu; Jun-Hui Yin; Qin-Fei Ke; He Xu; Chang-Qing Zhang; Ya-Ping Guo; You-Shui Gao
Journal:  Int J Nanomedicine       Date:  2019-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.